Decreased platelet responsiveness to clopidogrel correlates with CYP2C19 and PON1 polymorphisms in atherosclerotic patients

Clopidogrel and aspirin are the most commonly used medications worldwide for dual antiplatelet therapy after percutaneous coronary intervention. However, clopidogrel hyporesponsiveness related to gene polymorphisms is a concern. Populations with higher degrees of genetic admixture may have increased...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Braz J Med Biol Res
Päätekijät: Marchini, J.F.M., Pinto, M.R., Novaes, G.C., Badran, A.V., Pavão, R.B., Figueiredo, G.L., Lago, I.M., Lima-Filho, M.O., Lemos, D.C., Tonani, M., Antloga, C.M., Oliveira, L., Lorenzi, J.C., Marin-Neto, J.A.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Associação Brasileira de Divulgação Científica 2017
Aiheet:
Clinical Investigation
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5264542/
https://ncbi.nlm.nih.gov/pubmed/28076455
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1590/1414-431X20165660
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia